Home / Investor / Press Release / WOCKHARDT RECEIVES US FDA QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FOR WCK 6777, A FIRST EVER ONCE – A – DAY SS – LACTAM ENHANCER CLASS ANTIBIOTIC
Home ⁄ Press Release ⁄ WOCKHARDT RECEIVES US FDA QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FOR WCK 6777, A FIRST EVER ONCE – A – DAY SS – LACTAM ENHANCER CLASS ANTIBIOTIC
WOCKHARDT RECEIVES US FDA QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATION FOR WCK 6777, A FIRST EVER ONCE – A – DAY SS – LACTAM ENHANCER CLASS ANTIBIOTIC
